PATENT CLAIM ANALYSIS

Application Number: 16161413
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-08
Patent Classification: ["514", "443000"]

Abstract:
The present invention relates to a novel naphtho class of compounds as Stat3 pathway inhibitors and as cancer stem cell inhibitors; to methods of using such compounds to treat cancer; to methods of using such compounds to treat disorders in a mammal related to aberrent Stat3 pathway activity; to pharmaceutical compositions containing such compounds.

Claim (Index 3):
A pharmaceutical composition comprising a compound or a pharmaceutically-acceptable salt thereof as claimed in  claim 1 , or a pharmaceutically acceptable salt or solvate thereof, and a pharmaceutically-acceptable excipient, carrier, or diluent.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.70588
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14499299', '12677511', '14445783', '14208170', '15987525']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8030417692859196
- 35 USC 102 Novelty (BERT): 0.6077968129506333
- Combined Prediction Score: 0.783517273652391
- Mean Citation Score: 432.10478600000016
- Max Citation Score: 550.5484
- Similarity Product: 498.0882480441093

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test